Sissel Rodahl
Corporate Officer/Principal at GENSIGHT BIOLOGICS S.A.
Sissel Rodahl active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Corporate Officer/Principal | 2022-01-30 | - |
Career history of Sissel Rodahl
Former positions of Sissel Rodahl
| Companies | Position | Start | End |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 2018-08-31 | 2022-01-31 |
Training of Sissel Rodahl
| University of Oslo | Graduate Degree |
| Engineering College | Undergraduate Degree |
Statistics
International
| Norway | 3 |
| France | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Sissel Rodahl
- Experience
